| abstract |
The present invention provides a pharmaceutical composition comprising a compound found in Hardener secretion, treatment of dry eye syndrome in humans comprising administering an effective amount of a compound found in Hardener secretion, for example, ophthalmically, A pharmaceutical composition comprising the lipid compound as identified by the characteristic chemical data and mass spectra of the lipid compound, an essentially pure form of the lipid compound, and a compound present in the secretion of the therapeutic agent and horseradish, e.g., For example, the present invention relates to an ophthalmic vehicle comprising a lipid compound found in the secretion of Haldasem, for example, the rabbit. |